888.435.2220
info@medicure.com
MPH.V
Toggle navigation
Home
Products
Aggrastat (tirofiban HCI)
In Development
Business Development
Generic Products
Tardoxal
Apicore
News
News Releases
Get News Alerts by Email
Investors
Overview
Corporate Presentation
Corporate Governance
About Us
About Medicure
Management
Board of Directors
Careers
Corporate Compliance
Contact
News Releases
News
News Releases
News Releases
Get News Alerts by Email
Get News Alerts by Email
All Years
2017
2016
2015
2014
2013
2012
2011
Go
Advanced Search
Search
Search Headlines Only
From
To
Oct 30, 2013
Medicure Reports First Quarter Financial Results for Fiscal 2014
Oct 11, 2013
Medicure Announces Approval of Recommended Dosing Regimen for AGGRASTAT®
Sep 27, 2013
Medicure Reports Financial Results for Fiscal 2013
May 10, 2013
Medicure Announces Grant of Options
Apr 29, 2013
Medicure Reports Third Quarter Financial Results for Fiscal 2013
Feb 28, 2013
Dr. Albert D. Friesen to File Early Warning Report
Jan 28, 2013
Medicure Reports Second Quarter Financial Results for Fiscal 2013
Jan 22, 2013
Medicure Appoints Brent Fawkes to Board of Directors
Jan 8, 2013
Medicure Announces Filing of sNDA for AGGRASTAT Label Change
Nov 5, 2012
Medicure Announces Agreement to Promote Aggrastat® in the Commonwealth of Puerto Rico
Show
5
10
25
50
100
per page
«
1
2
3
4
5
6
7
8
9
»
